Testing insulin‐like growth factor messenger RNA–binding protein 3 as a surrogate immunohistochemical marker for indeterminate thyroid nodules with THADA fusion in both cytologic and surgical specimens
The current findings in a limited cohort demonstrate that IMP3 is a promising surrogate marker for indeterminate thyroid nodules with THADA fusions in both cytologic and surgical specimens. In addition, IMP3 staining may aid in detecting subtle capsular or vascular invasion.
Authors
- Scott Michael Steward-Tharp (ORCID: https://orcid.org/0000-0002-5865-4539)
- Qiuying Shi (ORCID: https://orcid.org/0000-0002-0224-3167)
- Noah S. Kalman (ORCID: https://orcid.org/0000-0003-1299-3014)
- Di Ai (ORCID: https://orcid.org/0000-0003-2972-4582)
- Wen-Yu Hsiao
- Youjie Zhang
- Kartik Viswanathan
- Jilun Zhang
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Emory University (US)
- Oregon Health & Science University (US)
- Baylor College of Medicine (US)
- University of Massachusetts Boston (US)
Publication Details
- Journal
- Cancer Cytopathology
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1002/cncy.70076
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00